These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2637044)

  • 1. Recognition in cell adhesion. A comparative study of the conformations of RGD-containing peptides by Monte Carlo and NMR methods.
    Cachau RE; Serpersu EH; Mildvan AS; August JT; Amzel LM
    J Mol Recognit; 1989 Dec; 2(4):179-86. PubMed ID: 2637044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conformational analysis of biologically active RGD-containing cyclopentapeptides].
    Kostetskiĭ PV; Artem'ev IV
    Bioorg Khim; 2000 Apr; 26(4):290-8. PubMed ID: 10857021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aqueous conformation of cyclo(1,6)Ac-Cys-Arg-Gly-Asp-Phe-Pen-NH2.
    Siahaan TJ; Bruss D; Powell NA; Chakrabarti S; Conrad M
    Int J Pept Protein Res; 1994 Nov; 44(5):427-34. PubMed ID: 7896500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic pentapeptides as models for reverse turns: determination of the equilibrium distribution between type I and type II conformations of Pro-Asn and Pro-Ala beta-turns.
    Stradley SJ; Rizo J; Bruch MD; Stroup AN; Gierasch LM
    Biopolymers; 1990 Jan; 29(1):263-87. PubMed ID: 2328290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide inhibitors of fibronectin, laminin, and other adhesion molecules: unique and shared features.
    Yamada KM; Kennedy DW
    J Cell Physiol; 1987 Jan; 130(1):21-8. PubMed ID: 3805128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides.
    Gurrath M; Müller G; Kessler H; Aumailley M; Timpl R
    Eur J Biochem; 1992 Dec; 210(3):911-21. PubMed ID: 1483474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1.
    Aumailley M; Gurrath M; Müller G; Calvete J; Timpl R; Kessler H
    FEBS Lett; 1991 Oct; 291(1):50-4. PubMed ID: 1718779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferred conformations of RGDX tetrapeptides to inhibit the binding of fibrinogen to platelets.
    Park HS; Kim C; Kang YK
    Biopolymers; 2002 Apr; 63(5):298-313. PubMed ID: 11877740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational study of cyclo(1,5)-Ac-Pen-Arg-Gly-Asp-Cys-NH2 in water by NMR and molecular dynamics.
    Siahaan TJ; Chakrabarti S; Vander Velde D
    Biochem Biophys Res Commun; 1992 Sep; 187(2):1042-7. PubMed ID: 1530602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta VI turns in peptides and proteins: a model peptide mimicry.
    Müller G; Gurrath M; Kurz M; Kessler H
    Proteins; 1993 Mar; 15(3):235-51. PubMed ID: 8456095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of conformational equilibrium of peptides in solution by NMR spectroscopy and theoretical conformational analysis: application to the calibration of mean-field solvation models.
    Groth M; Malicka J; Rodziewicz- Motowidło S; Czaplewski C; Klaudel L; Wiczk W; Liwo A
    Biopolymers; 2001; 60(2):79-95. PubMed ID: 11455544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis and modeling of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme.
    Yamada T; Uyeda A; Kidera A; Kikuchi M
    Biochemistry; 1994 Oct; 33(39):11678-83. PubMed ID: 7522552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of specific antibodies directed to the binding domain of adhesive molecules.
    Berliner SA; Roberts JR; Thorn ML; Ruggeri ZM
    Pept Res; 1988; 1(2):60-4. PubMed ID: 2485226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologically active Arg-Gly-Asp oligopeptides assume a type II beta-turn in solution.
    Johnson WC; Pagano TG; Basson CT; Madri JA; Gooley P; Armitage IM
    Biochemistry; 1993 Jan; 32(1):268-73. PubMed ID: 8418846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced conformational sampling in Monte Carlo simulations of proteins: application to a constrained peptide.
    Kidera A
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9886-9. PubMed ID: 7568238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
    Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH
    J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution conformation of a model hexapeptide containing RGD sequence.
    Dhingra MM
    Indian J Biochem Biophys; 1992 Dec; 29(6):458-64. PubMed ID: 1294461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-adhesive and anti-thrombotic effects of integrin-inhibiting tripeptides (Arg-Gly-Asp)].
    Udvardy M
    Orv Hetil; 1995 Oct; 136(40):2155-9. PubMed ID: 7566948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary structure of the Arg-Gly-Asp recognition site in proteins involved in cell-surface adhesion. Evidence for the occurrence of nested beta-bends in the model hexapeptide GRGDSP.
    Reed J; Hull WE; von der Lieth CW; Kübler D; Suhai S; Kinzel V
    Eur J Biochem; 1988 Dec; 178(1):141-54. PubMed ID: 3203684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
    Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.